Dr. Andreev-Drakhlin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
St. Petersburg State Medical UniversityClass of 2013
Certifications & Licensure
CA State Medical License 2021 - 2025
TX State Medical License 2019 - 2025
PA State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsMolecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade.Habib Hamidi, Yasin Senbabaoglu, Niha Beig, Juliette Roels, Cyrus Manuel
Cancer Cell. 2024-12-09 - 2 citationsAdjuvant Atezolizumab in Patients with Sarcomatoid Renal Cell Carcinoma: A Prespecified Subgroup Analysis of IMmotion010.Jose Antonio Karam, Robert Uzzo, Axel Bex, William Leung, Connie Tat
European Urology Oncology. 2024-12-01 - 4 citationsPlatinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment.Shilpa Gupta, Alexander Andreev-Drakhlin, Otto Fajardo, Marcella Fassò, Jorge A Garcia
Journal of the National Cancer Institute. 2024-04-05
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
